ProShares UltraPro Nasdaq Biotechnology (UBIO)

Add to Watchlists
Create an Alert
30.43 -1.38  -4.34% NASDAQ Apr 19, 20:00 Delayed 2m USD
View Full Chart
UBIO Price Chart
View All UBIO News

UBIO News

UBIO Performance

  Total Return (Price) Total Return (NAV) Cat. Total Return (NAV) % Rank in Cat. (NAV)
1M -14.71% -14.63% -- --
3M -21.08% -21.12% -- --
6M -22.11% -22.09% -- --
YTD -9.54% -9.42% -- --
1Y 15.35% 15.42% -- --
3Y -- -- -- --
5Y -- -- -- --
10Y -- -- -- --
As of April 19, 2018. Returns for periods of 1 year and above are annualized.

UBIO Asset Allocation

Type % Net % Long % Short
Cash -200.2% 18.08% 218.3%
Stock 81.92% 81.92% 0.00%
Bond 0.00% 0.00% 0.00%
Convertible 0.00% 0.00% 0.00%
Preferred 0.00% 0.00% 0.00%
Other 218.3% 218.3% 0.00%
As of March 31, 2018
View More Holdings

UBIO Top 10 Holdings

Symbol Name % Weight Price % Chg
-- Nasdaq Biotechnology Index Swap Ubs Ag 116.0% -- --
-- Nasdaq Biotechnology Index Swap Bank Of America Na 62.58% -- --
-- Nasdaq Biotechnology Index Swap Societe Generale 34.14% -- --
CELG Celgene Corp 6.91% 89.62 -1.53%
GILD Gilead Sciences Inc 6.42% 74.44 -1.64%
BIIB Biogen Inc 6.38% 266.02 -0.75%
AMGN Amgen Inc 6.24% 172.93 -1.24%
-- Nasdaq Biotechnology Index Swap Goldman Sachs International 5.60% -- --
VRTX Vertex Pharmaceuticals Inc 4.57% 159.55 -2.33%
REGN Regeneron Pharmaceuticals Inc 3.56% 315.83 -1.73%
As of March 31, 2018
Advertisement

UBIO Basic Info

Style
Equity Style Large Cap/Growth
Broad Asset Class Alternative
Broad Category Alternative
Category Name Trading--Leveraged Equity
Prospectus Objective Specialty - Technology
Fund Owner Firm Name ProShares
Benchmark Index
NASDAQ Biotechnology TR USD
300.0%

UBIO Manager Info

Name Tenure
Devin Sullivan 1.34 yrs
Michael Neches 2.62 yrs

UBIO Net Fund Flows

1M -1.595M
3M -11.74M
6M -2.276M
YTD -11.74M
1Y -11.08M
3Y --
5Y --
10Y --
As of March 31, 2018

UBIO Risk Info

Beta (5Y) --
Max Drawdown (All) 84.16%
Historical Sharpe (10Y) --
Historical Sortino (All) -0.2349
30-Day Rolling Volatility 83.55%
Daily Value at Risk (VaR) 1% (All) 13.08%
Monthly Value at Risk (VaR) 1% (All) 50.17%

UBIO Comparables

Edit

UBIO Attributes

Key Dates
Inception Date 6/22/2015
Termination Date
Last Annual Report Date 5/31/2017
Last Prospectus Date 10/1/2017
Attributes
Exchange Traded Share Yes
Exchange Traded Note No
Enhanced Index Fund No
Index Fund Yes
Inverse Fund No
Leveraged Fund Yes
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan No
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available for RRSP No

UBIO Excel Add-In Codes

  • Name: =YCI("UBIO","name")
  • Broad Asset Class: =YCI("UBIO", "broad_asset_class")
  • Broad Category: =YCI("UBIO", "broad_category_group")
  • Prospectus Objective: =YCI("UBIO", "prospectus_objective")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.